Pharma R&D Today

Making the Promise of Immunotherapeutics into Reality

Posted on August 2nd, 2017 by Patricia Morgan

This is an exciting and hopeful time for cancer research, as new therapies and approaches are being explored that offer an alternative to standard chemotherapy, which can be effective but often carries a number of harsh side effects. Continue reading “Making the Promise of Immunotherapeutics into Reality” »

Creating a Formula for Precise, Effective Literature Searching

Posted on July 31st, 2017 by Neal Katz

Even those who are old enough to remember the days before the internet might find it hard to imagine living our lives now without access to digital information tools. People working in pharmacovigilance today may actually shudder at the thought of having to do their jobs without biomedical research solutions. Continue reading “Creating a Formula for Precise, Effective Literature Searching” »

The Link Between Big Pharma and the Supplement Industry

Posted on July 28th, 2017 by Betsy Davis

When the FDA updated some of its guidelines around dietary supplements last year, many critics of the supplement (or “nutraceutical”) business were pleased to see a bit more regulation in an industry that enjoys surprisingly little oversight. Continue reading “The Link Between Big Pharma and the Supplement Industry” »

Seeing Research Through a Scientist’s Eyes

Posted on July 26th, 2017 by Dr. Anton Yuryev

If it’s your job to create and maintain information solutions designed to be used by scientists, it probably helps if you have real-world experience conducting scientific research, right? Continue reading “Seeing Research Through a Scientist’s Eyes” »

Hopes, Issues, and Concerns in Tackling the Challenge of Dementia

Posted on July 24th, 2017 by Dr Andrew A. Parsons

With recent failures of large Phase 3 studies targeting the amyloid pathways, there is perhaps a need for some good news for scientists, clinicians, health services and the general public. Recently, there was some good news in the media. Continue reading “Hopes, Issues, and Concerns in Tackling the Challenge of Dementia” »

Maryland Attempts to Control Drug Prices

Posted on July 21st, 2017 by Betsy Davis

Consumer concerns over the price of drugs remain high, so it’s not surprising that Maryland recently passed a bill aimed at controlling costs. Continue reading “Maryland Attempts to Control Drug Prices” »

About this Blog

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.